Craig A Jaffe
Biographic Data
| ID | 5417618 |
|---|---|
| NAME | Craig A Jaffe |
| GIVEN NAMES | Craig A |
| FAMILY NAME | Jaffe |
| SIGNATURE | JAFFE C A |
| AFFILIATIONS | University of Washington |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 4 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1999 |
| LATEST PUBLICATION YEAR | 2007 |
| H-INDEX | 1 |
An Open-Label Pilot Study of Risperidone in the Treatment of Methamphetamine Dependence
Psychopharmacological treatments for methamphetamine (MA) dependence have questionable efficacy. Open-label risperidone was evaluated in veterans seeking MA dependence treatment. Participants (N = 11) received four weeks of risperidone. They provided weekly self-reports of substance use, urine drug screens, and adverse effects. Neuropsychological assessments and psychiatric symptomatology (Brief Symptom Inventory; BSI) were measured at baseline a…
Single Dose of 24 Milligrams of Buprenorphine for Heroin Detoxification
Previous studies indicate that buprenorphine has efficacy in medically supervised opioid withdrawal, but the optimal dosing for maximum tolerability and ease of administration remains undetermined. Five heroin-dependent individuals entered this open-label study of inpatient detoxification with a single 24 mg dose of buprenorphine. The mean Clinical Opiate Withdrawal Scale (COWS) score prior to buprenorphine administration was 17.6 (SD = 3.36). CO…
Treatment Satisfaction Compared with Outcome in Severe Dual Disorders
Treatment Satisfaction Compared with Outcome in Severe Dual Disorders
Single Dose of 24 Milligrams of Buprenorphine for Heroin Detoxification
Previous studies indicate that buprenorphine has efficacy in medically supervised opioid withdrawal, but the optimal dosing for maximum tolerability and ease of administration remains undetermined. Five heroin-dependent individuals entered this open-label study of inpatient detoxification with a single 24 mg dose of buprenorphine. The mean Clinical Opiate Withdrawal Scale (COWS) score prior to buprenorphine administration was 17.6 (SD = 3.36). CO…
An Open-Label Pilot Study of Risperidone in the Treatment of Methamphetamine Dependence
Psychopharmacological treatments for methamphetamine (MA) dependence have questionable efficacy. Open-label risperidone was evaluated in veterans seeking MA dependence treatment. Participants (N = 11) received four weeks of risperidone. They provided weekly self-reports of substance use, urine drug screens, and adverse effects. Neuropsychological assessments and psychiatric symptomatology (Brief Symptom Inventory; BSI) were measured at baseline a…
Medicine (3 works) · Adverse effect (2 works) · Internal Medicine (2 works) · Psychiatry (2 works) · Psychology (2 works) · Addiction (1 works) · Anesthesia (1 works) · Attachment and Relationship Dynamics (1 works) · Attention Deficit Hyperactivity Disorder (1 works) · Buprenorphine (1 works)